These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 9747912

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
    Beltman F, Heesen W, Smit A, May J, de Graeff P, Havinga T, Schuurman F, van der Veur E, Lie K, Meyboom-de Jong B.
    J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
    [Abstract] [Full Text] [Related]

  • 23. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
    Amici E, Patruno N, Natale E, Marsocci A, Gambelli G.
    Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M, Boffano GM, Procopio M, Reynaud S, Allemano P, Rizzi G.
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T, Shigematsu M.
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [Abstract] [Full Text] [Related]

  • 29. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
    Sau F, Seguro C, Lai C, Onnis E, Orani E, Soro A, Leo MR, Cherchi A.
    Cardiologia; 1993 Jun; 38(6):369-76. PubMed ID: 8402746
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA, Ratti G, Aquino D, Caccavale A, Acitorio M, Rocereto A, Cosimi R, Coppolino P, Iarussi D, Iacono A.
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [Abstract] [Full Text] [Related]

  • 37. Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression.
    Cohen A, Bregman B, Agabiti Rosei E, Williams B, Dubourg O, Clairefond P, Brudi P, Gosse P, Guéret P.
    J Hum Hypertens; 1998 Jul; 12(7):479-83. PubMed ID: 9702935
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.